# Epidemiologic Cohort Study of Interstitial Cystitis

Source: https://welltoldgrants.com/grants/rfa-dp-24-031-epidemiologic-cohort-study-of-interstitial-cystitis/  
Official notice: https://www.grants.gov/search-results-detail/348751

> Centers for Disease Control and Prevention - ERA offered grants of up to $900,000 (at least $800,000) to any type of organization. It expected to make one award worth $4.2 million in total. Applications closed on February 9, 2024.

| Field | Value |
|---|---|
| Opportunity number | RFA-DP-24-031 |
| Agency | Centers for Disease Control and Prevention - ERA |
| Status | Forecast |
| Deadline | February 9, 2024 |
| Award ceiling | $900,000 |
| Award floor | $800,000 |
| Expected awards | 1 |
| Total funding | $4.2 million |
| Cost sharing | not required |
| Assistance Listings | 93.945 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

This NOFO is open competition

## What the grant funds

The purpose of the research NOFO is follow a cohort of interstitial cystitis (IC) patients over time, define the demographic and clinical patterns of IC, and document its impact on the health of affected people. In addition, the focus of this NOFO will include translating the scientific knowledge on IC extracted from previously funded and other studies so it can be used to support public health action, including patient strategies for improving quality of life, provider awareness and education, and medical and self-management of IC; strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC.

## Questions people ask

### Is RFA-DP-24-031 still open?

No. It closed on February 9, 2024. A newer notice is forecast: CDC-RFA-DP-27-0068, expected deadline April 30, 2027.

### Who can apply for Epidemiologic Cohort Study of Interstitial Cystitis?

Centers for Disease Control and Prevention - ERA accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Epidemiologic Cohort Study of Interstitial Cystitis?

Closed February 9, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $900,000 each. About $4.2 million in total for one award.

### Who has won Assistance Programs for Chronic Disease Prevention and Control grants before?

The largest recipients over five fiscal years were National Association of Chronic Disease Directors, Inc., Michigan Department of Health and Human Services, Emory University. The program made 437 awards worth $453 million in that time.